Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Genetics
Volume 2013 (2013), Article ID 951710, 4 pages
http://dx.doi.org/10.1155/2013/951710
Case Report

Fetoplacental Discrepancy with Normal Karyotype in Amniotic Fluid and Two Different Cell Lines in Placenta

1Department of Pathology, University of Texas Health Science Center, San Antonio, TX 78229, USA
2Center for Maternal and Fetal Care, San Antonio, TX 78229, USA

Received 26 April 2013; Accepted 26 May 2013

Academic Editors: A. DeWan, C. Julier, and A. Sazci

Copyright © 2013 Veronica Ortega et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Ferguson and S. A. Myers, “Population study of the risk of fetal death and its relationship to birthweight, gestational age, and race,” American Journal of Perinatology, vol. 11, no. 4, pp. 267–272, 1994. View at Google Scholar · View at Scopus
  2. D. S. Dizon-Townson, L. Meline, L. M. Nelson, M. Varner, and K. Ward, “Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction,” American Journal of Obstetrics and Gynecology, vol. 177, no. 2, pp. 402–405, 1997. View at Publisher · View at Google Scholar · View at Scopus
  3. D. H. Ledbetter, J. M. Zachary, J. L. Simpson et al., “Cytogenetic results from the U.S. collaborative study on CVS,” Prenatal Diagnosis, vol. 12, no. 5, pp. 317–345, 1992. View at Publisher · View at Google Scholar · View at Scopus
  4. A. S. P. M. Breed, A. Mantingh, R. Vosters, J. R. Beekhuis, J. M. M. Van Lith, and G. J. P. A. Anders, “Follow-up and pregnancy outcome after a diagnosis of mosaicism in CVS,” Prenatal Diagnosis, vol. 11, no. 8, pp. 577–580, 1991. View at Google Scholar · View at Scopus
  5. D. K. Kalousek, P. N. Howard-Peebles, S. B. Olson et al., “Confirmation of CVS mosaicism in term placentae and high frequency of intrauterine growth retardation association with confined placental mosaicism,” Prenatal Diagnosis, vol. 11, no. 10, pp. 743–750, 1991. View at Google Scholar · View at Scopus
  6. J. M. Hahnemann and L. O. Vejerslev, “Accuracy of cytogenetic findings on chorionic villus sampling (CVS)—diagnostic consequences of CVS mosaicism and non-mosaic discrepancy in centres contributing to EUCROMIC 1986–1992,” Prenatal Diagnosis, vol. 17, no. 9, pp. 801–820, 1997. View at Google Scholar
  7. D. K. Kalousek and M. Vekemans, “Confined placental mosaicism,” Journal of Medical Genetics, vol. 33, no. 7, pp. 529–533, 1996. View at Google Scholar · View at Scopus
  8. I. Filges, A. Kang, V. Klug et al., “aCGH on chorionic villi mirrors the complexity of fetoplacental mosaicism in prenatal diagnosis,” Prenatal Diagnosis, vol. 31, no. 5, pp. 473–478, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. D. K. Kalousek, I. J. Barrett, and B. C. McGillivray, “Placental mosaicism and intrauterine survival of trisomies 13 and 18,” American Journal of Human Genetics, vol. 44, no. 3, pp. 338–343, 1989. View at Google Scholar · View at Scopus
  10. D. K. Kalousek, S. Langlois, I. Barrett et al., “Uniparental disomy for chromosome 16 in humans,” American Journal of Human Genetics, vol. 52, no. 1, pp. 8–16, 1993. View at Google Scholar · View at Scopus
  11. C. Farra, B. Guidicelli, M. C. Pellissier, N. Philip, and C. Piquet, “Fetoplacental chromosomal discrepancy,” Prenatal Diagnosis, vol. 20, pp. 190–193, 2000. View at Google Scholar
  12. R. M. Bertina, B. P. C. Koeleman, T. Koster et al., “Mutation in blood coagulation factor V associated with resistance to activated protein C,” Nature, vol. 369, no. 6475, pp. 64–67, 1994. View at Publisher · View at Google Scholar · View at Scopus
  13. S. R. Poort, F. R. Rosendaal, P. H. Reitsma, and R. M. Bertina, “A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis,” Blood, vol. 88, no. 10, pp. 3698–3703, 1996. View at Google Scholar · View at Scopus
  14. L. G. Shaffer, M. L. Slovak, and L. J. Campbell, Eds., ISCN 2009. An International System for Human Cytogenetic Nomenclature, S. Karger, Basel, Switzerland, 2009.
  15. W. S. Long, M. T. Mennuti, B. S. Emanuel, and E. H. Zackai, “Prenatal diagnosis of mosaicism 46,XX/46,XX,-21,+t(21q21q),” Prenatal Diagnosis, vol. 4, no. 1, pp. 73–77, 1984. View at Google Scholar · View at Scopus
  16. G. Lissalde-Lavigne, P. Fabbro-Peray, E. Cochery-Nouvellon et al., “Factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first intended pregnancy: the matched case-control “NOHA first” study,” Journal of Thrombosis and Haemostasis, vol. 3, no. 10, pp. 2178–2184, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Grandone, M. Margaglione, D. Colaizzo et al., “Factor V Leiden is associated with repeated and recurrent unexplained fetal losses,” Thrombosis and Haemostasis, vol. 77, no. 5, pp. 822–824, 1997. View at Google Scholar · View at Scopus
  18. B. Brenner, G. Sarig, Z. Weiner, J. Younis, Z. Blumenfeld, and N. Lanir, “Thrombophilic polymorphisms are common in women with fetal loss without apparent cause,” Thrombosis and Haemostasis, vol. 82, no. 1, pp. 6–9, 1999. View at Google Scholar · View at Scopus
  19. G. Sarig, J. S. Younis, R. Hoffman, N. Lanir, Z. Blumenfeld, and B. Brenner, “Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastage,” Fertility and Sterility, vol. 77, no. 2, pp. 342–347, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Warburton and B. Strobino, “Recurrent spontaneous abortion,” in Spontaneous and Recurrent Abortion, M. J. Bennet and D. K. Edmonds, Eds., pp. 77–89, Blackwell Scientific, Oxford, UK, 1987. View at Google Scholar